Tetracaineside effects

The following serious ocular adverse reactions are described elsewhere in the labeling: Corneal injury with Intracameral Use Corneal Toxicity Corneal Injury due to Insensitivity The following adverse reactions have been identified following use of Tetracaine Hydrochloride Ophthalmic Solution 0.5%. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Ocular Adverse Reactions Transient stinging, burning, and conjunctival redness, eye irritation, eye pain, ocular discomfort.

Ocular adverse events: stinging, burning, conjunctival redness To report SUSPECTED ADVERSE REACTIONS, contact Alcon Laboratories, Inc., at 1-800-757-9195 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.